International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
A bedside equation to estimate 24‑h proteinuria in children with nephrotic syndrome: Derivation and temporal validation
To date, 24‑h urine protein (24hUP) excretion remains the gold standard for quantifying proteinuria and is a strong predictor of renal outcomes in glomerular diseases. Although current guidelines allow nephrotic‑range proteinuria to be diagnosed using either single‑void urine protein‑creatinine ratio (UPCR) or 24hUP thresholds, these cut‑offs primarily confirm disease presence and provide limited quantitative guidance for clinical decision‑making during the acute phase of pediatric primary nephrotic syndrome (PNS). The present study thus aimed to provide a method with which to estimate 24hUP in children with PNS. A total of 251 children with PNS were included and divided into a derivation cohort (n=171) and an independent validation cohort (n=80). Log‑log linear regression models were constructed using UPCR adjusted by estimated 24‑h creatinine excretion derived from the Cockcroft‑Gault, Hellerstein and Ghazali‑Barratt equations, with age and sex incorporated as covariates. Model performance was assessed using coefficients of determination (R2), root mean square error (RMSE), mean absolute error (MAE) and calibration analyses. The optimal model, based on Cockcroft‑Gault‑adjusted UPCR, demonstrated good predictive performance in external validation (RMSE, 11.39 mg/m2/h; MAE, 9.26 mg/m2/h; R2, 0.91), with 93.8 and 96.3% of estimates within 20 and 30% of observed 24hUP values, respectively. The application of the model indicated that a substantial proportion of children could safely avoid immediate 24‑h urine collection without missing cases of marked proteinuria. On the whole, a bedside equation using adjusted UPCR may serve as a practical surrogate for estimating 24hUP in children with PNS and facilitate clinical decision‑making in routine practice.